The aim of this study was to determine the potential epigenetic modifications and mRNA expression levels of BDNF and COMT at the periphery and to determine combinations of biomarkers that would yield the largest predictive values for differentiation between patients with AD and MCI. This evidence concerns the gene COMT and Alzheimer disease.